Parnax Lab Ltd (PARNAXLAB) is currently trading at 111.85 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Parnax Lab Limited, formerly Krishna Deep Trade & Investment Ltd, was incorporated in 1982 and is engaged in manufacturing and exporting pharmaceutical formulations. Naxpar Pharma Private Limited, a subsidiary, has over two decades of expertise in pharmaceuticals and is acclaimed for innovation in cosmetics, herbal formulations, and nutraceuticals. The company is recognized for its high-quality manufacturing standards, holding ISO 9002 certification from RWTUV, Germany, for its good quality systems. Naxpar's competitive manufacturing edge includes state-of-the-art facilities located in Silvassa and Baddi, serving a diverse international clientele. Strategically, Naxpar is poised for expansion into South East Asia, CIS, and LatAm, leveraging its WHO approval and compliance with international EHS standards.

Over the past 52 weeks, Parnax Lab Ltd has traded between a low of ₹99.20 and a high of ₹182.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Parnax Lab Ltd has a market capitalization of approximately 128.58. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Parnax Lab Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 14.37 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 128.58 Cr, Parnax Lab Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Parnax Lab Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Parnax Lab Ltd is 14.37. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.